ESCMID Logo

30 June 2015

Dear Colleagues,



Having trouble viewing this email? View in your browser.

Guideline on diagnosis and treatment of biofilms published in CMI

The ESCMID guideline for the diagnosis and treatment of biofilm infections 2014 has been published in our journal Clinical Microbiology and Infections (CMI). Biofilms cause chronic infections in tissues or by developing on the surfaces of medical devices. Many of them are difficult to diagnose and treat efficiently due to the inflammatory response surrounding the biofilm. Selected hallmark biofilm infections in tissues (e.g. cystic fibrosis with chronic lung infection, patients with chronic wound infections) or associated with devices (e.g. orthopaedic alloplastic devices, endotracheal tubes, intravenous catheters, indwelling urinary catheters, tissue fillers) are the main focus of the guideline, but it may be applied to other biofilm infections.

Researchers from EFWISG contribute to paper published in Eurosurveillance

Researchers of the ESCMID Food- and Water-borne Infections Study Group contributed to the study entitled Event-based surveillance of food- and waterborne diseases in Europe: ‘urgent inquiries’ (outbreak alerts) during 2008 to 2013, which was published in Eurosurveillance. The authors of the paper conclude that the platform to facilitate the timely exchange of information between countries has strengthened the role of the Food- and Waterborne Diseases and Zoonoses (FWD) network. Combined with outbreak data collected by the European Food Safety Authority (EFSA), the urgent inquiries give a good overview of the outbreaks’ characteristics. Their analysis, however, also showed that the coordination between the risk assessors and risk managers at the EU/EEA level has to improve, particularly when events are reported. They propose to develop cross-sectoral guidelines for outbreak reporting.

ECCs share expertise and provide observers with valuable experience

You find ESCMID Collaborative Centres across the globe and with a large range of specialties. If you are looking to strengthen your knowhow in infection control for example, you could spend some time with Prof. Jordi Rello at the Clinical Research & Innovation in Pneumonia & Sepsis (CRIPS) at the Vall d'Hebron University Hospital in Barcelona. CRIPS is a leading research group, with a particular interest in sepsis, pneumonia and severe infections in critically ill patients. It offers world-class research in nosocomial infections, community-acquired pneumonia and severe influenza infection. The tertiary 1300-bed teaching hospital has highly specialized microbiology, ID and critical care departments. Clinical care is organized by three teams (Immucompromised, Neurocritical and Medical-Surgical teams) under the leadership of Prof. Rello. Multidisciplinary rounds are conducted daily by fully certified critical care specialists with ID physicians, haematologists, surgeons and respiratory consultants. The observership offers an excellent opportunity to interact with both, the microbiology and the infectious diseases departments.

 
 
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173 info@escmid.org
www.escmid.org
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.
 
You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.